Related Experiment Video
Updated: May 5, 2026
10:37
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
9.3K
[Multidisciplinary guideline irritable bowel syndrome].
Hèlen Woutersen-Koch1, André J P M Smout, Carla E Flik
1Nederlands Huisartsen Genootschap, Utrecht.
Nederlands Tijdschrift Voor Geneeskunde
|December 12, 2013
Summary
This guideline details diagnosing and managing irritable bowel syndrome (IBS) through multidisciplinary collaboration. It emphasizes lifestyle advice and non-pharmacological treatments over medication, with psychotherapy as an option for severe cases.
Area of Science:
- Gastroenterology
- Internal Medicine
- Psychology
Background:
- Irritable bowel syndrome (IBS) diagnosis relies on criteria like Rome III, but requires excluding organic conditions first.
- Effective IBS management necessitates a coordinated approach among various healthcare professionals.
Purpose of the Study:
- To establish a multidisciplinary guideline for the diagnosis and treatment of IBS.
- To foster collaboration between IBS patients and healthcare providers.
Main Methods:
- Diagnosis based on established criteria (e.g., Rome III) after ruling out other conditions.
- Treatment prioritizes lifestyle advice, patient education, and non-pharmacological interventions.
- Psychotherapeutic options are considered for refractory cases impacting quality of life.
Main Results:
- Somatic conditions must be excluded before additional diagnostic tests for IBS.
- Non-pharmacological management is the primary approach, with drug treatment rarely indicated.
- Referrals to occupational health physicians or dietitians are recommended for work-related issues or dietary imbalances.
Conclusions:
- A collaborative, multidisciplinary approach is crucial for optimal IBS patient care.
- Conservative management, including lifestyle changes and education, should precede pharmacological interventions.
- Psychotherapy, occupational health consultation, and dietary guidance are valuable adjuncts for specific IBS patient needs.
More Related Videos
Related Concept Videos
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
989
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
989
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
1.0K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K
01:23Irritable Bowel Syndrome
36
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility...
36
01:17Irritable Bowel Syndrome I: Introduction
1.4K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.4K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
1.0K
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K
01:17Chronic Bowel Disorders: Introduction
900
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900